Stock Analysis
CME Group Inc. (CME) Stock Analysis
CME Group Inc. (CME) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
CME Group Inc. (CME) currently has an AIQ Score of 57/100, indicating a neutral setup. Sentiment is the strongest factor at 80/100. Value is the weakest current factor at 25/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CME at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $303.14 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $109.93B |
| P/E Ratio (TTM) | 24.94 |
| Forward P/E | — |
| EPS (quarter ended 2026-09-30) | $2.90 |
| Revenue (quarter ended 2026-09-30) | $1.74B |
| Dividend Yield (TTM) | 3.70% |
| Beta | 0.27 |
| Volume | 1.96M |
| 52-week range | $218.31-$329.16 |
| RSI 14 | 65 |
| 50-Day SMA | $279.69 |
| 200-Day SMA | $280.05 |
| Analyst Price Target | $314.72 |
| Next Earnings | Feb 3, 2027 |
CMECME Group Inc.
Financial Services / Financial - Data & Stock Exchanges
Low Priority
Above Peers
Latest quote
- Momentum76
- Value25
- Quality74
- Risk resilience53
- Sentiment80
CME Stock Analysis Summary
CME Group Inc. (CME) currently has an AIQ Score of 57/100, indicating a neutral setup. Sentiment is the strongest factor at 80/100. Value is the weakest current factor at 25/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CME has AIQ Score of 57/100 with Sentiment base of 80/100 and fading Value at 25/100. Wait for component alignment before adding exposure.
Sentiment (80/100) leads while Value (25/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · 2.27% stock move · CME classified in Financial - Data & Stock Exchanges.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CME Bullish or Bearish Right Now?
CME currently has a neutral overall setup. Sentiment is the strongest factor at 80/100, while Value is weakest at 25/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 74/100.
- - Momentum is constructive at 76/100.
- - Price is +5.98% above its 50-day SMA.
- - Analyst target implies +3.82% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (32 vs 6).
- - Value is the current constraint at 25/100.
Current Consensus
CME's Technical Analysis Consensus is currently Strong Buy, with 32 buy, 7 neutral, and 6 sell votes. CME's 14-day RSI is 65, which places the stock in a constructive momentum range. CME's beta is 0.27, indicating lower market sensitivity than the broad market.
What Changed in CME?
The largest recent change in CME is Momentum moving down by 12.0 points over the available 7-day comparison window. Sentiment remains the strongest visible factor.
What Would Change the CME Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CME Decision Framework
Public evidence layers, setup checks, and risk context for CME Group Inc..
CME Group Inc. (CME) Stock Analysis
CME Group Inc. has an AIQ Score of 57/100 in a Neutral regime. Sentiment is strongest at 80/100. Beta is 0.27, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CME is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 80/100 while value lags at 25/100. |
| Factor Evidence | Momentum 76/100 · Value 25/100 · Quality 74/100 · Risk 53/100 · Sentiment 80/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 80/100.
Momentum is 76/100 and RSI (14) is 65.0.
CME is in a Neutral regime at 57/100.
Risk factor is 53/100 with beta 0.27 and annual volatility 25.04%.
Current conflict: sentiment leads at 80/100 while value lags at 25/100.
CME Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CME Fundamentals
CME valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CME Technical Analysis
CME technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CME Stock Catalysts
Track CME earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CME Dividend Analysis
CME dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CME Financial Data
CME revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CME Risk Analysis
CME volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CME Stock News
CME stock news, market tone, recent headlines, and catalyst context.
CME vs Asset Management / Exchanges Peers
Current peer cohort: CME · EVR · FDS · FNF · HLNE. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CME Current stock | 57/100 | 25/100 | 76/100 | 53/100 | 0.47 | 25.04% | Current |
| EVR Evercore | 70/100 | 46/100 | 84/100 | 51/100 | 0.13 | 38.38% | CME vs EVR |
| FDS FactSet Research | 57/100 | 34/100 | 82/100 | 40/100 | 0.54 | 47.52% | CME vs FDS |
| FNF Fidelity National Financial | 63/100 | 67/100 | 52/100 | 80/100 | -1.14 | 27.47% | CME vs FNF |
| HLNE Hamilton Lane | 56/100 | 35/100 | 43/100 | 64/100 | -0.6 | 41.80% | CME vs HLNE |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CME
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CME
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CME Stock FAQ
What is CME stock price today?
CME Group Inc.'s current stock price is $303.14. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CME bullish or bearish right now?
CME's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CME's market cap?
CME's market cap is $109.93B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CME's current P/E ratio?
CME's current P/E ratio is 24.94 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CME's RSI?
CME's 14-day RSI is 65 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CME above its 50-day and 200-day moving averages?
CME is 5.98% from its 50-day SMA and 5.85% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CME's next earnings date?
CME's next earnings date is currently listed as Feb 3, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CME pay a dividend?
CME's dividend yield is 3.70% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.